Neutra Corp. specializes in the research, development, and provision of hemp-derived nutraceuticals. Its product portfolio features items such as CBD-infused sports creams, in addition to a variety of other health and wellness goods. Established in 2011, the company is headquartered in Sugar Land, Texas.
Sector: Medicinal Chemicals & Botanical Products
Industry: Biotechnology
Neutra Corp.
OTC:NTRRHealthcare · Biotechnology
Mkt Cap$584K
Float2.9B
Shares O/S2.92B
Inst Own-
Dilution
$0.0002
Mkt Cap$584K
Float2.9B
O/S2.92B
Inst Own-
Dilution
OTC:NTRR$0.0002
MCap$584K
Float2.9B
O/S2.92B
Inst Own-
Dilution
Form
Description
Links
15-12G
NOTICE OF TERMINATION OF REGISTRATION
10-Q
FORM 10-Q QUARTERLY REPORT FOR 04-30-2024
10-K
FORM 10-K ANNUAL REPORT FOR 01-31-2024
NT 10-Q
FORM 12B-25 NOTIFICATION OF LATE FILING (NT 10-Q) FOR 04-30-2024
8-K
FORM 8-K FOR 05-03-2024
NT 10-K
FORM 12B-25 (NT 10-K) NOTIFICATION OF LATE FILING FOR 01-31-2024
10-Q
FORM 10-Q QUARTERLY REPORT FOR 10-31-2023
10-Q
FORM 10-Q QUARTERLY REPORT FOR 07-31-2023
8-K
FORM 8-K FOR 08-01-2023
10-Q
FORM 10-Q QUARTERLY REPORT FOR 04-30-2023
NT 10-Q
FORM 12B-25 NOTIFICATION OF LATE FILING (NT 10-Q) FOR 04-30-2023
10-K
FORM 10-K ANNUAL REPORT FOR 01-31-2023
NT 10-K
FORM 12B-25 (NT 10-K) NOTIFICATION OF LATE FILING FOR 01-31-2023
10-Q
FORM 10-Q QUARTERLY REPORT FOR 10-31-2022
10-Q
FORM 10-Q QUARTERLY REPORT FOR 07-31-2022
10-Q
FORM 10-Q QUARTERLY REPORT FOR 04-30-2022
NT 10-Q
FORM 12B-25 NOTIFICATION OF LATE FILING (NT 10-Q) FOR 04-30-2022
10-K
FORM 10-K ANNUAL REPORT FOR 01-31-2022
NT 10-K
FORM 12B-25 (NT 10-K) FOR 01-31-2022
10-Q
FORM 10-Q QUARTERLY REPORT FOR 10-31-2021
10-Q
FORM 10-Q QUARTERLY REPORT FOR 07-31-2021
10-Q
FORM 10-Q QUARTERLY REPORT FOR 04-30-2021
NT 10-Q
FORM 12B-25 NOTIFICATION OF LATE FILING (NT 10-Q) FOR 04-30-2021
10-K/A
FORM 10-K/A AMENDMENT NO. 1 TO ANNUAL REPORT FOR 01-31-2021
